Well being-tech firm MediBuddy on Monday mentioned it raised USD 20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others.
The corporate had introduced an preliminary funding of USD 20 million in June final yr beneath the sequence B spherical, a press release mentioned.
“The extra infusion of USD 20 million led by India Life Sciences Fund III, LLC, with participation from different buyers,” it added.
The sequence B spherical has attracted new investments from India Life Sciences Fund III, LLC, TEAMFund LP, JAFCO Asia Fund, FinSight Ventures, ALES World Japan and Past Subsequent Ventures.
The spherical has additionally seen participation from current buyers together with Bessemer Enterprise Companions, Milliways Ventures and Rebright Companions. The corporate has raised over USD 50 million to date.
Based by Satish Kannan and Enbasekar, MediBuddy’s platform has a associate community of over 90,000 medical doctors, 7,000 hospitals, 3,000 diagnostic centres and a couple of,500 pharmacies, and a 1,000-member crew situated throughout 22 Indian cities.
“We’ll make the most of the funding in additional strengthening our physician and hospital base, affected person attain, product, expertise, and model; to maneuver a step nearer to our mission of offering high-quality healthcare to a billion folks,” MediBuddy co-founder and CEO Satish Kannan mentioned.
Moreover, the corporate has onboarded main business professionals over the previous few months to drive crucial areas, bolstering an already-strong management crew, he added.
Final week, InnoVen Capital had introduced investing Rs 25 crore in debt fund into MediBuddy. This debt fund is part of the USD 40 million spherical, Kannan mentioned.
(Solely the headline and film of this report could have been reworked by the Enterprise Normal workers; the remainder of the content material is auto-generated from a syndicated feed.)